% | $
Quotes you view appear here for quick access.

Agenus Inc. Message Board

  • perfectrob777 perfectrob777 Oct 8, 2013 11:36 AM Flag


    good time too add shares

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It is possible. GSK bought Corixa for $400M ($300M plus $100M debt) mainly for its MPL vaccine adjuvant.

      QS-21 basically is firmly integrated in GSK in the adjuvant system for the next generation vaccine (cancer and infectios disease).

      • 1 Reply to hufrd
      • The news yesterday shows that QS-21 is the real deal. QS-21 is in over 19 drugs in the pipeline, many of them through GSK. So a BUYOUT could be a potentiality, always. GSK gave AGEN $9,000,000 just for the right to negotiate to BUYOUT AGEN should another suitor come knocking on AGEN's door, so you know they are very interested, they just do not want to jump the gun and do anything immediately until it is necessary for their business.
        If we assumed GSK would pay about $300M for AGEN then that puts the share price somewhere at about $10 per share!!!
        Who knows, it could be announced after hours TODAY!!! My point is that you just never never know, these bio-techs are volatile. Out of all those 19 candidates in the pipeline, how many will have good news, possibly very positive data points??? Hmmm.....

        Sentiment: Strong Buy

5.55+0.170(+3.16%)Jul 29 4:00 PMEDT